• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular pathogenesis and molecular therapy in RUNX1-EVI1-type leukemia.

Research Project

Project/Area Number 19K08822
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54010:Hematology and medical oncology-related
Research InstitutionDokkyo Medical University

Principal Investigator

Mitani Kinuko  獨協医科大学, 医学部, 教授 (50251244)

Co-Investigator(Kenkyū-buntansha) 佐々木 光  獨協医科大学, 医学部, 准教授 (60282638)
市川 幹  獨協医科大学, 医学部, 准教授 (60463840)
中村 由香  獨協医科大学, 医学部, 講師 (80364595)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2021: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
KeywordsRUNX1-EVI1 / t(3;21) / 急性巨核芽球性白血病 / SKP2 / ヒストン脱アセチル化酵素阻害剤 / 内科 / 癌 / 遺伝子 / 分子標的療法
Outline of Research at the Start

急性骨髄性白血病の発症及び慢性骨髄性白血病や骨髄異形成症候群等の造血幹細胞腫瘍の白血病化には、転写因子遺伝子の機能異常が重要な役割を果たしている。本研究においては、これらの原因遺伝子RUNX1-EVI1の機能を、モデルマウスを使用して個体レベルで解析する。モデルマウスは移植実験によって得られたもので、急性巨核芽球性白血病を発症する。具体的には、RUNX1-EVI1の標的遺伝子の同定を行うとともに、白血病細胞の生存を支持している造血微小環境のニッチの機能を合わせて解析する。最終的には、これらの知見をもとにして、RUNX1-EVI1を標的とした分子治療の開発を目指す。

Outline of Final Research Achievements

RUNX1-EVI1 is a chimeric transcription factor generated by t(3;21) and causes the development of acute megakaryoblastic leukemia or transformation of chronic myelocytic leukemia and myelodysplastic syndrome. We created RUNX1-EVI1-type model mice by retroviral infection and transplantation experiments. By using primary leukemic cells derived from the mice, we investigated whether SKP2 is one of downstream targets for RUNX1-EVI1. Retroviral introduction of SKP2 inhibited their proliferation in cell culture, indicating that SKP2 could be a novel target of molecular therapy for RUNX1-EVI1-type leukemia.

Academic Significance and Societal Importance of the Research Achievements

RUNX1-EVI1型白血病は極めて予後が不良であり、化学療法のみでは治癒は困難である。今回作製されたモデルマウスを解析することにより、予後不良の白血病の発症機構が詳細に解明されることが期待される。また、これらの知見を基にして、今後新規の分子標的療法の開発が可能となる。RUNX1-EVI1はキメラ型転写因子でありヒストン脱アセチル化酵素阻害剤は有力な治療候補薬となるが、今後SKP2を標的とした分子標的療法が開発されることが期待される。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (17 results)

All 2022 2021 2020 2019 Other

All Journal Article (8 results) (of which Int'l Joint Research: 4 results,  Peer Reviewed: 8 results,  Open Access: 5 results) Presentation (7 results) (of which Int'l Joint Research: 1 results,  Invited: 2 results) Remarks (2 results)

  • [Journal Article] Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma.2022

    • Author(s)
      Nakamura F, Nakamura Y, Nannya Y, Arai H, Shimbo K, Nakamura Y, Seo S, Sasaki K, Ichikawa M, Ogawa S, Mitani.
    • Journal Title

      Leukemia Research Reports

      Volume: 17 Pages: 100305-100305

    • DOI

      10.1016/j.lrr.2022.100305

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] PECAM is an effective and safe anthracycline-containing regimen for patients with relapsed or refractory non-Hodgkin lymphoma.2021

    • Author(s)
      Nakamura F, Arai H, Tokita K, Furuichi S, Sugita-Nagasawa F, Takahashi W, Handa T, Iso H, Tadokoro J, Tsurumi S, Nakamura Y, Nakamura Y, Sasaki K, Seo S, Ichikawa M, Mitani K.
    • Journal Title

      Leukemia & Lympho

      Volume: 62 Issue: 1 Pages: 239-242

    • DOI

      10.1080/10428194.2020.1817442

    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Clonal hematopoiesis in adult pure red cell aplasia2021

    • Author(s)
      Fujishima N、Kohmaru J、Koyota S、Kuba K、Saga T、Omokawa A、Moritoki Y、Ueki S、Ishida F、Nakao S、Matsuda A、Ohta A、Tohyama K、Yamasaki H、Usuki K、Nakashima Y、Sato S、Miyazaki Y、Nannya Y、Ogawa S、Sawada K、Mitani K、Hirokawa M
    • Journal Title

      Scientific Reports

      Volume: 11 Issue: 1 Pages: 2253-2253

    • DOI

      10.1038/s41598-021-81890-5

    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.2021

    • Author(s)
      Nakamura F, Arai H, Nannya Y, Ichikawa M, Furuichi S, Nagasawa F, Takahashi W, Handa T, Nakamura Y, Tanaka H, Nakamura Y, Sasaki K, Miyano S, Ogawa S, Mitani K.
    • Journal Title

      Int J Hematol

      Volume: 113 Issue: 6 Pages: 936-940

    • DOI

      10.1007/s12185-020-03074-7

    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia.2021

    • Author(s)
      Ochi Y, Yoshida K, Huang YJ, Kuo MC, Nannya Y, Sasaki K, Mitani K, et al.
    • Journal Title

      Nat comm

      Volume: 12 Issue: 1 Pages: 2833-2833

    • DOI

      10.1038/s41467-021-23097-w

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] . Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.2020

    • Author(s)
      Jang JH, Tomiyama Y, Miyazaki K, Nagafuji K, Usuki K, Uoshima N, Fujisaki T, Kosugi H, Matsumura I, Sasaki K, Kizaki M, Sawa M, Hidaka M, Kobayashi N, Ichikawa S, Yonemura Y, Enokitani K, Matsuda A, Ozawa K, Mitani K, Lee JW, Nakao S.
    • Journal Title

      Br J Haematol.

      Volume: 192 Issue: 1 Pages: 190-199

    • DOI

      10.1111/bjh.17190

    • Related Report
      2021 Annual Research Report 2020 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells.2020

    • Author(s)
      Naka K, Ochiai R, Matsubara E, Kondo C, Yang KM, Hoshii T, Araki M, Araki K, Sotomaru Y, Sasaki K, Mitani K, Kim D-W, Ooshima A, Kim SJ.
    • Journal Title

      Nature Comm

      Volume: 11 Issue: 1 Pages: 4681-4681

    • DOI

      10.1038/s41467-020-18491-9

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma.2020

    • Author(s)
      Ishida T, Hideo Kimura H, Ozaki S, Kubo K, Sunami K, Takezako N, Fujita H, Hayashi8 T, Toru Kiguchi T, Ohashi K, Yamamoto S, Takamatsu H, Kosugi H, Ohta K, Sakai R, Handa H, Kondo Seiji, Abe Y, Omoto E, Mitani K, Morita S, Murakami H, Shimizu K.
    • Journal Title

      Annals of Hematology

      Volume: - Issue: 5 Pages: 1063-1072

    • DOI

      10.1007/s00277-020-03988-6

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Presentation] 急性白血病の分子病態と分子標的療法.2021

    • Author(s)
      三谷絹子
    • Organizer
      日本癌治療学会
    • Related Report
      2021 Annual Research Report
    • Invited
  • [Presentation] Clonal evolution and clinical impact of genetic lesions in blast crisis of chronic myeloid leukemia.2021

    • Author(s)
      越智 陽太郎、吉田 健一、南谷 泰仁、佐々木 光、三谷 絹子、小川 誠司等
    • Organizer
      日本血液学会 関東甲信越地方会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ASXL1 mutations predict a poor response to darbepoetin alfa in anemic patients with low-risk MDS.2020

    • Author(s)
      Hirohiko Shibayama, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, Hitoshi Hanamoto, Yoshinobu Maeda, Tomoko Hata, Toshihiro Miyamoto, Hiroshi Kawabata, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, Itaru Matsumura, Seishi Ogawa, Koichi Akashi, Yuzuru Kanakura, Kinuko Mitani
    • Organizer
      第82回日本血液学会学術集会総会
    • Related Report
      2020 Research-status Report
  • [Presentation] Prognostic Relevance of Genetic Abnormalities in Blastic Transformation of Chronic Myeloid Leukemia.2020

    • Author(s)
      Yotaro Ochi, Kenichi Yoshida, Ko Sasaki, Yasuhito Nannya, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Satoru Miyano, Kinuko Mitani, Seishi Ogawa, et al.
    • Organizer
      第62回米国血液学会
    • Related Report
      2020 Research-status Report
  • [Presentation] ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-risk MDS: A Multicenter, Phase II Study.2020

    • Author(s)
      Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, Hirohiko Shibayama, Yoshinobu Maeda, Tomoko Hata, Toshihiro Miyamoto, Hiroshi Kawabata, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, Itaru Matsumura, Seishi Ogawa, Koichi Akashi, Yuzuru Kanakura, Kinuko Mitani.
    • Organizer
      第62回米国血液学会
    • Related Report
      2020 Research-status Report
  • [Presentation] 慢性骨髄性白血病の病態進展におけるMIR9の機能.2019

    • Author(s)
      佐々木光、永澤英子、吉田健一、竹田淳恵、白石友一、千葉健一、田中洋子、岡田 愛、宮野 悟、市川 幹、小川誠司、三谷絹子
    • Organizer
      第56回日本臨床分子医学会学術集会.
    • Related Report
      2019 Research-status Report
  • [Presentation] Myelodysplastic syndromes ~Recent progresses in molecular and immune therapies~.2019

    • Author(s)
      Kinuko Mitani
    • Organizer
      5th Asean Federation of Hematology
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research / Invited
  • [Remarks] 獨協医科大学 内科学(血液・腫瘍)研究紹介 基礎研究

    • URL

      https://dept.dokkyomed.ac.jp/dep-m/hematol/research_basic.html

    • Related Report
      2021 Annual Research Report
  • [Remarks] 獨協医科大学 内科学(血液・腫瘍)

    • URL

      https://dept.dokkyomed.ac.jp/dep-m/hematol/

    • Related Report
      2020 Research-status Report

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi